Description: Jardiance 10 mg Tablets are an oral medication used to improve blood sugar control in adults with type 2 diabetes. As part of a complete treatment plan that includes diet and exercise, Jardiance helps lower blood glucose levels by removing excess sugar through the urine. It also offers cardiovascular benefits, reducing the risk of heart-related complications in diabetic patients.
Ingredients:
- Active Ingredient: Empagliflozin (10 mg per tablet)
- Other Ingredients: Lactose monohydrate, microcrystalline cellulose, hydroxypropyl cellulose, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide, and other excipients.
Usage Instructions:
- The typical dose is one 10 mg tablet taken once daily in the morning, with or without food.
- Swallow the tablet whole with a glass of water.
- Consistently take the medication at the same time each day.
- Follow your healthcare provider’s instructions regarding dosage and any necessary adjustments.
Benefits:
- Helps lower blood sugar levels in adults with type 2 diabetes.
- Aids in the reduction of hemoglobin A1c (HbA1c) levels.
- Provides cardiovascular benefits, reducing the risk of heart attack, stroke, and cardiovascular death in diabetic patients.
- Can assist in weight loss due to the excretion of excess glucose.
Precautions:
- Not suitable for individuals with severe kidney problems, type 1 diabetes, or diabetic ketoacidosis.
- Possible side effects include urinary tract infections, yeast infections, increased urination, and dehydration.
- May cause dizziness or fainting due to low blood pressure.
- Inform your healthcare provider of all other medications you are taking to avoid potential interactions.
- Not recommended for use during pregnancy or breastfeeding without medical advice.
- Regular kidney function monitoring is advised during treatment.
Storage Instructions:
- Store at a temperature below 30°C (86°F).
- Keep the tablets in their original packaging to protect them from moisture and light.
- Keep out of reach of children.
Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
